Drug
Alks 37
Alks 37: highest development phase Phase 2, developed by Alkermes. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Alkermes
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALKS 37 NCT01382797 | Phase 2 | Opioid-induced Constipation |
Latest
No recent events.
Follow Alks 37 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.